Whittington Hospital is a district general and teaching hospital of UCL Medical School and Middlesex University School of Health and Social Sciences.

There are 360 beds in Whittington Hospital.

During the past decade, Whittington Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Whittington Hospital" #1 sponsor was "University College, London" with 6 trials, followed by "Cancer Research UK" with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Institute of Cancer Research, United Kingdom" with 2 trials sponsored and "Shire" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Whittington Hospital" #1 collaborator was "The Whittington Hospital NHS Trust" with 3 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Barnet and Chase Farm Hospitals NHS Trust" with 1 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "Guy's and St Thomas' NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Whittington Hospital" are "Breast Cancer" (6 trials), "Colorectal Cancer" (3 trials), "Sickle Cell Disease" (3 trials), "Beta-thalassemia" (2 trials) and "Critical Illness" (2 trials). Many other conditions were trialed in "Whittington Hospital" in a lesser frequency.

Most popular intervention types in "Whittington Hospital" are "Drug" (18 trials), "Procedure" (8 trials), "Other" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (3 trials), "Luspatercept" (2 trials), "Placebo" (2 trials), "capecitabine" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Whittington Hospital" are 20 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Whittington Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Whittington Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Whittington Hospital, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".